TVTX: Cline Christopher R. discloses securities transactions
By AlphaYouPublished Form 4
Cline Christopher R.
Reporting filer
Cline Christopher R. reported Exercise or conversion in Travere Therapeutics, Inc.: 20000 units of Common Stock, dated 2026-09-15. The full Form 4 contains 6 transaction entries.
- Disclosed
- Sep 18, 2026
Reported details
6 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Cline Christopher R. | 2026-09-15 | M | Exercise or conversion | 20000 | 17.44 | 138,016 | 3 days | Filed terms
|
| Common Stock | Cline Christopher R. | 2026-09-15 | S | Sale | 27473 | 61.9969 | 110,543 | 3 days | Filed terms
|
| Common Stock | Cline Christopher R. | 2026-09-15 | S | Sale | 20735 | 62.6079 | 89,808 | 3 days | Filed terms
|
| Common Stock | Cline Christopher R. | 2026-09-15 | S | Sale | 1900 | 63.6865 | 87,908 | 3 days | Filed terms
|
| Common Stock | Cline Christopher R. | 2026-09-15 | S | Sale | 400 | 65.31 | 87,508 | 3 days | Filed terms
|
| Employee stock option (right to buy) (derivative) | Cline Christopher R. | 2026-09-15 | M | Exercise or conversion | 20000 | 0 | 0 | 3 days | Filed terms
|
Common Stock
- Owner
- Cline Christopher R.
- Date
- 2026-09-15
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 20000
- Price
- 17.44
- Following holdings
- 138,016
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-15
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Shares: 20000
- transaction Price Per Share: 17.44
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 138016
- direct Or Indirect Ownership: D
- nature Of Ownership:
Common Stock
- Owner
- Cline Christopher R.
- Date
- 2026-09-15
- Code
- S
- Action
- Sale
- Quantity
- 27473
- Price
- 61.9969
- Following holdings
- 110,543
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-15
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 27473
- transaction Price Per Share: 61.9969
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 110543
- direct Or Indirect Ownership: D
- nature Of Ownership:
Common Stock
- Owner
- Cline Christopher R.
- Date
- 2026-09-15
- Code
- S
- Action
- Sale
- Quantity
- 20735
- Price
- 62.6079
- Following holdings
- 89,808
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-15
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 20735
- transaction Price Per Share: 62.6079
- id: F3
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 89808
- direct Or Indirect Ownership: D
- nature Of Ownership:
Common Stock
- Owner
- Cline Christopher R.
- Date
- 2026-09-15
- Code
- S
- Action
- Sale
- Quantity
- 1900
- Price
- 63.6865
- Following holdings
- 87,908
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-15
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 1900
- transaction Price Per Share: 63.6865
- id: F4
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 87908
- direct Or Indirect Ownership: D
- nature Of Ownership:
Common Stock
- Owner
- Cline Christopher R.
- Date
- 2026-09-15
- Code
- S
- Action
- Sale
- Quantity
- 400
- Price
- 65.31
- Following holdings
- 87,508
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-15
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 400
- transaction Price Per Share: 65.31
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 87508
- direct Or Indirect Ownership: D
- nature Of Ownership:
Employee stock option (right to buy) (derivative)
- Owner
- Cline Christopher R.
- Date
- 2026-09-15
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 20000
- Price
- 0
- Following holdings
- 0
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Employee stock option (right to buy)
- conversion Or Exercise Price: 17.44
- transaction Date: 2026-09-15
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Shares: 20000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F5
- expiration Date: 2027-05-17
- underlying Security Title: Common Stock
- underlying Security Shares: 20000
- shares Owned Following Transaction: 0
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Cline Christopher R.: CHIEF FINANCIAL OFFICER.
- The filing reports a Rule 10b5-1 trading plan.
- F1: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares underlying a stock option granted to the Reporting Person with an expiration date of May 17, 2027.
- F2: The weighted average sale price for the transaction reported was $61.9969, and the range of prices were between $61.38 and $62.37. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
- F3: The weighted average sale price for the transaction reported was $62.6079, and the range of prices were between $62.38 and $63.30. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
- F4: The weighted average sale price for the transaction reported was $63.6865, and the range of prices were between $63.59 and $63.86. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
- F5: The stock option is fully vested and exercisable.
Original sources
Prepared automatically from public filing data. Report a correction.